Skip Navigation


NDT Advance Access originally published online on April 2, 2008
Nephrology Dialysis Transplantation 2008 23(7):2198-2205; doi:10.1093/ndt/gfn090
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/7/2198    most recent
gfn090v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Luo, J.
Right arrow Articles by Hishida, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, J.
Right arrow Articles by Hishida, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats

Jinghui Luo, Takayuki Tsuji, Hideo Yasuda, Yuan Sun, Yoshihide Fujigaki and Akira Hishida

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan

Correspondence and offprint requests to: Hideo Yasuda, First Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan. E-mail: ysdh{at}hama-med.ac.jp, ysdh{at}mac.com



  Abstract

Background. The clinical use of cisplatin (cis-diamminedichloro-platinum II, CDDP) is highly limited by its nephrotoxicity. Although N-acetylcysteine (NAC), a thiol-containing antioxidant, has been documented to be effective in attenuating renal injury induced by CDDP, the precise mechanisms involved in its renoprotection have not been completely clarified.

Methods. We investigated the effects of NAC on oxidative stress and oxidation-associated signals, such as p38 mitogen-activated protein kinase (MAPK), NF-{kappa}B and TNF-{alpha}, in CDDP-induced acute renal failure (ARF) rats, in comparison to the effects of melatonin (MT), one of the physiological TNF-{alpha} inhibitors, and pyrrolidine dithiocarbamate (PDTC), a NF-{kappa}B inhibitor.

Results. NAC blocked oxidative stress, p38 MAPK activation, caspase-3 cleavage, tissue apoptosis, renal dysfunction and morphological damage induced by CDDP. CDDP-triggered NF-{kappa}B translocation into the nucleus and TNF-{alpha} mRNA increase in the kidney were also inhibited in NAC-treated rats. MT downregulated the TNF-{alpha} mRNA level, and PDTC inhibited the increases in both NF-{kappa}B translocation and TNF-{alpha} mRNA. Neither MT nor PDTC were capable of interfering with oxidative stress, p38 MAPK phosphorylation, caspase-3 cleavage, tissue apoptosis and kidney injury induced by CDDP.

Conclusions. These data suggest that oxidative stress and p38 MAPK-mediated apoptotic cell death pathways are involved, at least in part, in the pathogenesis of CDDP-induced ARF, and negative regulation of p38 MAPK activation through inhibition of oxidative stress appears to play a central role in the beneficial effects of NAC.

Keywords: acute renal failure; cisplatin; N-acetlycysteine; p38 mitogen-activated protein kinase

Received for publication: 21. 6.07
Accepted in revised form: 30. 1.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
K. P. Kang, D. H. Kim, Y. J. Jung, A. S. Lee, S. Lee, S. Y. Lee, K. Y. Jang, M. J. Sung, S. K. Park, and W. Kim
Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation
Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3012 - 3020.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. W. Stout-Delgado, X. Yang, W. E. Walker, B. M. Tesar, and D. R. Goldstein
Aging Impairs IFN Regulatory Factor 7 Up-Regulation in Plasmacytoid Dendritic Cells during TLR9 Activation
J. Immunol., November 15, 2008; 181(10): 6747 - 6756.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Jiang and Z. Dong
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 300 - 307.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.